Zimmer Biomet's Stock Slump: A Buying Opportunity or a Sign of Deeper Trouble?
Shares of medical device giant Zimmer Biomet Holdings (ZBH) have faced recent pressure, reigniting the debate over its valuation. While some analysts see a significant discount to fair value, investors are weighing competitive threats and integration risks from recent acquisitions.